Lupin Ltd Drug Patent Portfolio
Lupin Ltd owns 1 orange book drug protected by 1 US patent Given below is the list of Lupin Ltd's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9233112 | Pharmaceutical compositions of cefixime | 14 Dec, 2028 | Active |
Lupin Ltd's Family Patents
Recent FDA approvals and tentative approvals for Lupin Ltd
This section lists recent FDA approvals and tentative approvals for Lupin, covering innovator and generic drugs with key regulatory details and timelines.
Innovator drugs
Includes innovator drug submissions that appear in FDA approval and tentative approval disclosures.
| Drug Name | Submission class (FDA) | Submission Category | Submission Date |
|---|---|---|---|
| Dolutegravir;lamivudine;tenofovir Alafenamide |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Type 4 - New Combination | 18 Jul, 2023 |
| Dolutegravir; Emtricitabine; Tenofovir Alafenamide |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Type 4 - New Combination | 19 Jan, 2023 |
| Dolutegravir, Lamivudine And Tenofovir Disoproxil Fumarate |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Type 4 - New Combination | 25 Jun, 2021 |
Generic drugs
Includes generic drug submissions with tentative FDA approvals, not yet marketable due to patent or exclusivity restrictions.
| Drug Name | Submission class (FDA) | Submission Category | Submission Date |
|---|---|---|---|
| Oxcarbazepine Extended Release Tablets |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 06 Jun, 2025 |
| Ivacaftor |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 08 Jan, 2025 |
| Abacavir; Dolutegravir; Lamivudine |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 03 Dec, 2024 |
Lupin Ltd Drug List
Given below is the complete list of Lupin Ltd's drugs and the patents protecting them.
1. Suprax
Suprax is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9233112 | Pharmaceutical compositions of cefixime |
14 Dec, 2028
(2 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Suprax's drug page